Tang Capital Management’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $104K | Buy |
|
|||||
|
2024
Q3 | $165K | Sell |
|
|||||
|
2024
Q2 | $714K | Buy |
|
|||||
|
2024
Q1 | $1.78K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $349K | Sell |
|
|||||
|
2022
Q3 | $14.8M | Hold |
|
|||||
|
2022
Q2 | $7.6M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $1.33M | Sell |
|
|||||
|
2021
Q3 | $2.62M | Hold |
|
|||||
|
2021
Q2 | $3.2M | Sell |
|
|||||
|
2021
Q1 | $7.04M | Hold |
|
|||||
|
2020
Q4 | $6.41M | Sell |
|
|||||
|
2020
Q3 | $18.8M | Hold |
|
|||||
|
2020
Q2 | $22.4M | Sell |
|
|||||
|
2020
Q1 | $44.3M | Hold |
|
|||||
|
2019
Q4 | $50.7M | Buy |
|